肾细胞癌
中文名称
通路描述
肾细胞癌(RCC)约占人类恶性肿瘤的3%,其发病率呈上升趋势。虽然大多数RCC病例为散发性,但遗传易感性导致肾癌占1-4%。RCC并非单一疾病,具有多种形态亚型。常规肾细胞癌(clear cell RCC)占80%,其次是乳头状肾细胞癌(10-15%)、透明细胞肾细胞癌(5%)和集合管肾细胞癌(<1%)。每种特定类型散发性肿瘤潜在涉及的基因分别为VHL、MET、BHD和FH。在缺乏VHL的情况下,缺氧诱导因子α(HIF-alpha)积累,导致多种生长因子(包括血管内皮生长因子和血小板衍生生长因子)的产生。激活的MET介导多种生物学效应,包括迁移、细胞外基质侵袭、细胞转化、防止凋亡和转移形成。功能丧失的FH导致细胞内富集草酸,触发抑制HPH,并阻止靶向pVHL介导的HIF-alpha降解。BHD突变导致Birt-Hogg-Dube综合征及其相关的透明细胞、混合嗜酸性细胞和常规(clear cell)肾细胞癌。
英文描述
PDH complex synthesizes acetyl-CoA from PYR The mitochondrial pyruvate dehydrogenase complex catalyzes the reaction of pyruvate, CoASH, and NAD+ to form acetylCoA, CO2, and NADH. The enzyme complex contains multiple copies of E1 alpha, E1 beta, E2, and E3, each with distinct catalytic activities (Reed and Hackert 1990; Zhou et al 2001), and the X-component (PDHX) which is required for anchoring E3 to E2 (Hiromasa et al., 2004; Vijayakrishnan et al., 2010). The reaction starts with the oxidative decarboxylation of pyruvate catalyzed by E1 alpha and beta (pyruvate dehydrogenase). Lipoamide cofactor associated with E2 is reduced at the same time. Next, the acetyl group derived from pyruvate is transferred to coenzyme A in two steps catalyzed by E2 (DLAT, dihydrolipolyl transacetylase). Finally, the oxidized form of lipoamide is regenerated and electrons are transferred to NAD+ in two steps catalyzed by E3 (DLD, dihydrolipoyl dehydrogenase). The biochemical details of this reaction have been worked out with pyruvate dehydrogenase complex and subunits purified from bovine tissue and other non-human sources. Direct evidence for the roles of the corresponding human proteins comes from studies of patients expressing mutant forms of E1 alpha (Lissens et al. 2000), E1 beta (Brown et al. 2004), E2 (Head et al. 2005), and E3 (Brautigam et al. 2005). The most common PDH complex deficiencies are caused by defects in PDHA and PDHX but can be caused by defects in any component of the complex (e.g. Pavlu-Pereira et al., 2020; reviewed in Prasad et al., 2011).
所含基因
6 个基因